Fundz

Synaptogenix reported raising $3.21 Million in an initial SEC Form D filing, from an offering of $3.21 Million

PRIVATESep 23, 2024

Amount Raised

$3.21 Million

$3.21 Million sold, per SEC Form D (first sale Sep 10, 2024)

Round Type

Seed

New YorkBiotechnologyHealth CareArtificial IntelligenceBlockchainCryptocurrencyTherapeuticsMachine Learning

Quick answer

Synaptogenix raised $3.21 Million in a Seed round, dated September 10, 2024. Synaptogenix is based in New York, New York, United States.

How much did Synaptogenix raise?
Synaptogenix raised $3.21 Million in a Seed round on September 10, 2024.
What does Synaptogenix do?
Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Where is Synaptogenix based and how big is it?
Synaptogenix is based in New York, New York, United States.
Who are the decision-makers at Synaptogenix?
Fundz holds 1 contact at Synaptogenix, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Blockchain and Cryptocurrency around the same time

Companies in the same sectors as Synaptogenix that raised within 45 days of this round, from Fundz verified event records.

  • Pathos AI raised $62M on October 24, 2024.
  • Shift Bioscience raised $16M (Seed) on October 15, 2024.
  • Pharos raised $5M (Seed) on October 25, 2024.
  • Integrated Biosciences raised $17M (Seed) on October 3, 2024.
  • Safe Superintelligence raised $1B (Convertible Note) on September 4, 2024.
  • GenLayer raised $7.5M (Seed) on August 21, 2024.

Who to call at Synaptogenix, and when

A new round usually means Synaptogenix is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Synaptogenix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synaptogenix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synaptogenix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synaptogenix

Location

1185 AVENUE OF THE AMERICAS

New York, New York, United States

About

Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. Synaptogenix has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synaptogenix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRobert W., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Synaptogenix's next move

See what Strategic adds

Synaptogenix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.